Category WHO

WHO Director Highlights Non-Communicable Diseases, Pandemics; Blasts Industry Counter-Efforts

World Health Organization Director General Margaret Chan today had strong messages for the opening day of the annual World Health Assembly: in these rocky times, public health work is a high ground that helps bring security and development, and if you are not doing all you can to advance global health for all, then you are part of the problem. She took a swipe at mega-industries – especially tobacco and junk food - that produce and market unhealthy products and spend heavily to work against effective public health policies.

Conference On Journalism And Health Looks At WHA Issues

On the eve of the 66th edition of the World Health Assembly, the World Health Editors Network (WHEN) and the Who’s There? Yes (WTY) convened for a conference on their new Journalism and Health Initiative. The conference, entitled, “Enter the stadium, democratise knowledge, bring it home,” focussed on increasing access and awareness of health policy and problems by the general public.

World Health Assembly: R&D, NCDs, Pandemics Top Agenda

With just days before the UN World Health Assembly opens, member states once again face a packed agenda with key decisions to be taken on some highly-politicised public health and intellectual property matters, including how to move forward on the research and development draft resolution. The spotlight will also be on pandemic influenza preparedness, a resolution of size on noncommunicable diseases, the health-related Millennium Development Goals, and putting some reform decisions into practice.

Global Public-Private Partnerships Against IP Crimes: How Interpol Avoided The Failures Of WCO And WHO

Christopher J. Paun writes: Public-private partnerships (PPPs) are often used as a way of increasing public policy options by tapping into private sector resources. This occurs also in the field of intellectual property. There are several examples of Global PPPs against IP crimes - some more successful than others. Some prominent failures received a lot of attention when PPP activities were stopped following controversy about global IP policy.

Curbing Vaccine Costs Key To Extending Global Immunisation Reach

As the World Health Organization kicks off a week devoted to the promotion of vaccines, newly published research has identified challenges, such as weak supply systems and information gaps, that need to be addressed to scale-up global vaccine coverage. But some observers say that more attention should be paid to the soaring costs of vaccines, starting with a mechanism to track prices.